SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-21-132786
Filing Date
2021-04-27
Accepted
2021-04-27 07:44:00
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d80529ddefa14a.htm DEFA14A 17838
2 GRAPHIC g80529g47t67.jpg GRAPHIC 376259
3 GRAPHIC g80529g64k58.jpg GRAPHIC 263432
  Complete submission text file 0001193125-21-132786.txt   899913
Mailing Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110
Business Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Filer) CIK: 0001771917 (see all company filings)

IRS No.: 270605902 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38958 | Film No.: 21855890
SIC: 2834 Pharmaceutical Preparations